Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Sanfilippo

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Critical Reviews in Oncology/Hematology|May 16, 2018
Role of bevacizumab in uterine leiomyosarcomaGiorgio Bogani, Antonino Ditto, Fabio Martinelli, et al.
Gynecologic Oncology|September 16, 2011
Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centersRoberta Sanfilippo, Federica Grosso, Robin L Jones, et al.
Cancers|April 3, 2021
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with TrabectedinChiara Fabbroni, Giovanni Fucà, Francesca Ligorio, et al.
Journal of Surgical Oncology|December 17, 2018
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysisEran Nizri, Marco Fiore, Chiara Colombo, et al.
Clinical Sarcoma Research|August 31, 2017
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcomaVittoria Colia, Marco Fiore, Salvatore Provenzano, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2022
Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohortStefano Radaelli, Sandro Pasquali, Chiara Colombo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2015
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trialIvalina Hristova, Ronald Boellaard, Wouter Vogel, et al.
Clinical Sarcoma Research|September 3, 2020
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centersGiovanni Fucà, Chiara Fabbroni, Rosanna Mancari, et al.
Acta Oncologica (Stockholm, Sweden)|July 21, 2017
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study<sup></sup>Hans Gelderblom, Ian R Judson, Charlotte Benson, et al.
Annals of Surgical Oncology|July 18, 2019
Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal PrognosisEran Nizri, Marco Fiore, Francesco Barretta, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|May 16, 2018
Role of bevacizumab in uterine leiomyosarcomaGiorgio Bogani, Antonino Ditto, Fabio Martinelli, et al.
Gynecologic Oncology|September 16, 2011
Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centersRoberta Sanfilippo, Federica Grosso, Robin L Jones, et al.
Cancers|April 3, 2021
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with TrabectedinChiara Fabbroni, Giovanni Fucà, Francesca Ligorio, et al.
Journal of Surgical Oncology|December 17, 2018
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysisEran Nizri, Marco Fiore, Chiara Colombo, et al.
Clinical Sarcoma Research|August 31, 2017
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcomaVittoria Colia, Marco Fiore, Salvatore Provenzano, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2022
Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohortStefano Radaelli, Sandro Pasquali, Chiara Colombo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2015
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trialIvalina Hristova, Ronald Boellaard, Wouter Vogel, et al.
Clinical Sarcoma Research|September 3, 2020
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centersGiovanni Fucà, Chiara Fabbroni, Rosanna Mancari, et al.
Acta Oncologica (Stockholm, Sweden)|July 21, 2017
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study<sup></sup>Hans Gelderblom, Ian R Judson, Charlotte Benson, et al.
Annals of Surgical Oncology|July 18, 2019
Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal PrognosisEran Nizri, Marco Fiore, Francesco Barretta, et al.
Pageof 9